Lisa Filaferro, MBA, PHR

🌾 𝗪𝗵𝗲𝗮𝘁'𝘀 𝗪𝗲𝗲𝗸𝗹𝘆!! 🌾   #WheatsWeekly - August always feels quiet on LinkedIn, but we do have some exciting CDMO updates to share!   𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀   ✅ Eli Lilly and Company open their new 12-story innovation center in the Boston Seaport, occupying 346,000 square feet!   🔐 Ajinomoto Bio-Pharma Services lay off 71 staff members at California site after the Forge Biologics acquisition.   𝗠&𝗔 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   🤝 Evotec and Bristol Myers Squibb further progress their strategic partnership, triggering a $75 million performance and program based milestone payment to Evotec.   🇫🇮 Nanoform and Takeda collaborate on on plasma-derived therapy development.   𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   🏭 CiVentiChem has completed a new facility in Hyderabad, significantly expanding its manufacturing capacity by 300%.   🧬 Evonik expands formulation capabilities for lipid nanoparticles using KNAUER's scientific instruments. 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   💰Phosphorex receive new investment from NOF AMERICA CORPORATION to accelerate the establishment of their cGMP capabilities for enhanced collaboration and innovation in nanoparticle-based drug delivery.   𝗡𝗲𝘄 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽   🌟 Britton Jimenez is names the new SVP of Commercial Ops at Codexis, Inc.   👨‍🔬 Tanguy Le Talaer is named Head of CDMO Sales & Marketing at Sentiss Pharma Pvt. Ltd. 💫 Amit Thakkar, PhD, PMP is named VP of BD at Suven Pharmaceuticals.   Did I miss anything, let me know in the comments! 👇   #CDMO #pharma #biotech

48

Quiz Time - Retaining top talent in life sciences can be challenging. What do you think is the most effective way to stop your team from leaving for new opportunities? A) Offering competitive pay and benefits packages B) Creating a strong sense of purpose and mission C) Providing clear paths for career advancement D) Fostering a supportive and engaging work environment 👇 See if you got it right - Find the answer here: https://bit.ly/3U5tazN #LifeSciences #EmployeeRetention #WorkplaceCulture #Leadership #CareerGrowth #TalentManagement #EmployeeEngagement #HRStrategies

1

🚀 Success Story: Accelerating Hiring for CRCs Across the US 🚀 At Hobson Prior, we pride ourselves on delivering exceptional staffing solutions tailored to the unique needs of our clients. Recently, we partnered with a leading Site Management Organization (SMO) to streamline their recruitment process for Clinical Research Coordinators (CRCs) across the United States. The Challenge: The SMO faced significant delays in hiring CRCs, impacting their project timelines and overall efficiency. Our Solution: Leveraging our extensive network and expertise in the life sciences sector, we implemented a strategic recruitment plan that significantly reduced hiring time. Our approach ensured that the SMO could quickly onboard qualified CRCs without compromising quality. The Result: The SMO experienced a remarkable improvement in their hiring process, filling critical positions faster and more efficiently. And the best part? There was no additional cost for this accelerated service. We are thrilled to have played a role in their success and look forward to continuing to support their growth. If you’re facing similar challenges, let’s connect and explore how Hobson Prior can help you achieve your recruitment goals. #LifeSciences #Recruitment #ClinicalResearch #HiringSuccess #HobsonPrior

4

Want to learn more about who has the best pay in Life Sciences?  Read our blog, "Who Has the Best Pay in Life Sciences? A Study," by SRG SVP of Delivery & Strategy, Patrick H. Stedman, and see how careers have evolved over the years and why the job market is more attractive than ever. Learn about the views of over 4,000 #STEM industry professions on hybrid working, AI, diversity, culture, and what candidates want in an employer.  Our SRG Talent Trends & Insights report was done in partnership with New Scientist Jobs, which has been tracking the salaries of professional scientists for more than 20 years. The goal was to quantify earnings and how they are changing and study the differences by geography, demographics, and skills. Read more below:  https://lnkd.in/euDnRxPa

15

Great opportunities

5

Routine health screenings are critical, especially when it comes to aggressive cancers. Research shows that the reduction in cancer deaths is attributed more to cancer screenings and catching cancer earlier than advancements in cancer treatment itself. Another alarming consideration is the number of Oncologists exiting practice compared to those entering practice. Medical Oncologists are among the oldest physicians, with almost 75% being 55 or older. There is an expected US shortage of 2,250 Oncologists by late 2025, leaving 66% of rural counties and 32 million Americans who live in a county without an Oncologist. Continued education on the benefits of screening is important. Oncology recruitment is also critical for communities. If you are interested in learning more about AMN Healthcare Physician Solutions Oncology staffing services, message or email me directly at [email protected] https://lnkd.in/gugScei6

7

2 Comments

🦃 What is the ONE Word? 🦃 JOIN me for this weeks very SPECIAL, MSL Talk Podcast Thanksgiving episode. YES, it is a message about gratitude but with a very different spin from prior years. I talk about.... 👉 Gratitude practices and why Thanksgiving is so important 👉 What is the “Feeling” you are hoping for next Thanksgiving 👉 Why having a trigger word can keep you on track and inspired 👉 How to fully receive and experience gratitude The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.     MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #thanksgiving #careers    

13

4 Comments

🦃 What is the ONE Word? 🦃 JOIN me for this weeks very SPECIAL, MSL Talk Podcast Thanksgiving episode. YES, it is a message about gratitude but with a very different spin from prior years. I talk about.... 👉 Gratitude practices and why Thanksgiving is so important 👉 What is the “Feeling” you are hoping for next Thanksgiving 👉 Why having a trigger word can keep you on track and inspired 👉 How to fully receive and experience gratitude The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel. MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #thanksgiving #careers

13

1 Comment

Good news for those affected by schizophrenia: Over the past 45 years I've volunteered and mentored several women who have suffered with mental illness and addiction. Congratulations to Chris Boerner and his team at BMS for their commitment to follow this through to getting FDA approval! The FDA has approved a new drug called Cobenfy, developed by Bristol Myers Squibb, to treat schizophrenia. This is a big deal because it's the first new type of medication for schizophrenia in 35 years. The last time a new class of drugs for this condition was introduced was in 1989 with the approval of Clozaril. Cobenfy works differently than existing drugs because it targets specific brain receptors, and it has shown positive results in three major studies. These studies measured how well it worked using a common scale for assessing schizophrenia symptoms and found that Cobenfy helped improve both the positive and negative symptoms of the disorder. According to the FDA, this approval offers people with schizophrenia a new alternative to the antipsychotic medications they've been using, which could mean better treatment options moving forward. This new drug brings hope for improved care and quality of life for patients dealing with schizophrenia. Very good news!

2

Catch me if you can! Watch this past webinar about good catches hosted by Sean O'Neill, PharmD and Joanne Hatfield, PharmD, BCPS. Sean and Joanne shared good catch data from our network in a review of types of good catches detected by smart infusion pumps, trends in good catch data, including medication examples, strategies to enhance patient safety through library build. https://hubs.ly/Q02Q9H120

5

As NAMs are becoming more relevant and accessible in today’s chemical product development, Labcorp is innovating in vitro alternatives so clients around the globe can leverage these new assays. From standard techniques to novel solutions, we can identify an approach that fits your product’s specific regulatory requirements. Discover your NAM options today. #CropProtection #ChemicalDevelopment #InVitroStudyAlternatives #NewApproachMethodologies #NAMs

3

If You’re Looking to Transform TA at Your Company, You Need These 2 Things

1

One for my Diagnostic network - I'm interested to hear thoughts on the FDA's plan to bring LDTs into its regulatory fold over the next 4 years? What impact is this going to have on the market? 👇 ✏ #FDA #IVD #diagnostics #LDTs #labdevelopedtests #IVDS

2

The Medicus Firm's publications are the cornerstone of informed recruitment strategies. Dive into our 2023 surveys for invaluable insights into the healthcare job market. https://bit.ly/49OIENm #WeAreTMF #HealthcareRecruitment #HealthcareLeaders #MedicalEducation #PhysicianRecruitment #HealthcareProfessionals #HealthcareJobs​

3

In this PM360 article, our expert Cameron Thompson outlines two major shifts in engaging physicians. Dive in: https://ow.ly/1HQU30sBZcJ #SyneosHealth

7